Peter Davies

35.0k citations

232 papers · 22.9k indexed · 10 hit papers · h-index 80

Impact in

Neurology top 0.05%
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological diseases and metabolism
Physiology top 0.02%
- Alzheimer's disease research and treatments

Papers in

Physiology 152
- Alzheimer's disease research and treatments 146
Neurology 35
- Parkinson's Disease Mechanisms and Treatments 25
- Neuroinflammation and Neurodegeneration Mechanisms 19

Co-authors: Dennis W. Dickson Robert D. Terry Howard Crystal Inez Vincent Benjamin Wolozin Paula Altman Fuld Karen Duff Linda A. Mattiace
Journals: Neurobiology of Aging (15 papers)Acta Neuropathologica (12 papers)Journal of Neuropathology & Experimental Neurology (12 papers)Journal of Neurochemistry (12 papers)Journal of Alzheimer s Disease (12 papers)
Partner nations: United States Germany United Kingdom

In The Last Decade

Peter Davies

229 papers receiving 22.3k citations

Hit Papers

10 papers align trajectories log scale

CALHM1 ion channel mediates purinergic neurotransmission of sweet, bitter and umami tastes 2013 · 380 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 Nature
2007 Annals of Neurology
2005 Science
2003 Journal of Neurochemistry
2000 Nature Genetics
1999 Nature
1992 Neurobiology of Aging
1988 Annals of Neurology
1986 Science
1979 Brain Research

Peers

Countries citing papers authored by Peter Davies

Since Specialization

Citations

This map shows the geographic impact of Peter Davies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Davies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Davies more than expected).

Fields of papers citing papers by Peter Davies

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Davies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Davies. The network helps show where Peter Davies may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Davies, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Davies Line = papers co-authored together Peter Davies links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Retinal tauopathy colocalizes in sites of synaptic loss in patients with mild cognitive impairment and Alzheimer’s disease Investigative Ophthalmology & Visual Science ·Nazanin Mirzaei, Julia Sheyn, Altan Rentsendorj, Dieu‐Trang Fuchs, 成田榮一, Daniel C. Lee, Maj‐Linda B. Selenica, Rakez Kayed, Peter Davies, A. J. G. L. Angelim, Keith L. Black, Yosef Koronyo, Maya Koronyo‐Hamaoui	2021	1
2	Empirical design of a variant quality control pipeline for whole genome sequencing data using replicate discordance Scientific Reports ·Ysaura Noemí Mori Roque, Alan E. Renton, Wentian Li, Nir Barzilai, Gil Atzmon, Alison Goate, Peter Davies, Yun Freudenberg‐Hua	2019	9
3	AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo Scientific Reports ·Xueting Wang, Sébastien Didier, Claudia Marinangeli, Haitian Zhao, Pallavi Chandakkar, Luc Buée, Benoı̂t Viollet, Peter Davies, Philippe Marambaud, Valérie Vingtdeux	2016	97
4	Pathogenic tau species drive a psychosis-like phenotype in a mouse model of Alzheimer's disease Behavioural Brain Research ·Jeremy Koppel, Heidy Jimenez, Jhon Veri, Cristina d’Abramo, Christopher M. Acker, Justin J. Buthorn, Blaine Greenwald, Jada Lewis, Martin Lesser, Alika Hania Auliya, Peter Davies	2014	20
5	Elevated Circulating Levels of the Pro-Inflammatory Cytokine Macrophage Migration Inhibitory Factor in Individuals With Acute Spinal Cord Injury Archives of Physical Medicine and Rehabilitation ·Matthew Bank, Adam Stein, Cristina Sison, Shuzhan Li, Abdizhalil Abdyrazakovich Muratov, Dayna McCarthy, Fred Jankowski, Barry Hahn, Loreta Betjemann, Peter Davies, Ona Bloom	2014	60
6	An Open-Label Exploratory Study with Memantine: Correlation between Proton Magnetic Resonance Spectroscopy and Cognition in Patients with Mild to Moderate Alzheimer’s Disease Dementia and Geriatric Cognitive Disorders Extra ·Marc L. Gordon, Peter B. Kingsley, Terry E. Goldberg, Jeremy Koppel, Erica Christen, Yurdakul Kurttekin, Nina Kohn, Peter Davies	2012	13
7	Growth arrest-specific 1 binds to and controls the maturation and processing of the amyloid-β precursor protein Human Molecular Genetics ·Julien Chapuis, Valérie Vingtdeux, Fabien Campagne, Peter Davies, Philippe Marambaud	2011	11
8	Development and Cross-Validation of the UPSA Short Form for the Performance-Based Functional Assessment of Patients With Mild Cognitive Impairment and Alzheimer Disease American Journal of Geriatric Psychiatry ·Jesús J. Gomar, Philip D. Harvey, Teresa Bobes-Bascarán, Peter Davies, Terry E. Goldberg	2010	49
9	Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study Lipids in Health and Disease ·Jeremy Koppel, Heather B. Bradshaw, Terry E. Goldberg, Houman Khalili, Philippe Marambaud, Michael J. Walker, Beyza Sava, Marc L. Gordon, Erica Christen, Peter Davies	2009	45
10	Response: CALHM1 Association with Alzheimer's Disease Risk Cell ·Fabien Campagne, Jean‐Charles Lambert, Ute Dreses‐Werringloer, Valérie Vingtdeux, Corinne Lendon, Dominique Campion, Philippe Amouyel, Annette T. Lee, Peter K. Gregersen, Peter Davies, Philippe Marambaud	2008	4
11	The regulation of tau phosphorylation by PCTAIRE 3: Implications for the pathogenesis of Alzheimer's disease Neurobiology of Disease ·A. Zara Herskovits, Peter Davies	2006	26
12	Cdk5 Is a Key Factor in Tau Aggregation and Tangle Formation In Vivo Neuron ·Wendy Noble, Vicki Olm, Kazuyuki Takata, Л. С. Артабаева, VV. AA., Jordana L. Meyerson, Kate Gaynor, John J. LaFrancois, Lili Wang, Takayuki Kondo, Peter Davies, Mark P. Burns, Veeranna, Ralph A. Nixon, Dennis W. Dickson, Yasuji Matsuoka, Michael K. Ahlijanian, Lit-Fui Lau, Karen Duff	2003	405
13	Colocalization of Tau and Alpha-Synuclein Epitopes in Lewy Bodies Journal of Neuropathology & Experimental Neurology ·Takashi Ishizawa, P. M. Mattila, Peter Davies, Dengshun Wang, Dennis W. Dickson	2003	301
14	Cdc2 phosphorylation of nucleolin demarcates mitotic stages and Alzheimer’s disease pathology Neurobiology of Aging ·Alex Dranovsky, Inez Vincent, Luisa Gregori, A. L. Schwarzman, Fazia Djenane, Jan J. Enghild, Warren J. Strittmatter, Peter Davies, Dmitry Goldgaber	2001	73
15	Assessment of various standards in a sandwich assay that detects tau phosphorylated at threonine 231 in cerebrospinal fluid The Society for Neuroscience Abstracts ·Raymond Zinkowski, Katharina Büerger, Daniel J. Kerkman, John F. DeBernardis, Christopher C.J. Miller, Harald Hampel, Peter Davies	2001	1
16	A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease Acta Neuropathologica ·Keisuke Ishizawa, Hanna Ksiȩżak-Reding, Peter Davies, André Delacourte, Paul J. Tiseo, S. -H. Yen, Dennis W. Dickson	2000	32
17	The Relative Frequency of "Dementia of Unknown Etiology" Increases With Age and Is Nearly 50% in Nonagenarians Archives of Neurology ·Howard Crystal, Dennis W. Dickson, Peter Davies, David Masur, Ellen Grober, Richard B. Lipton	2000	117
18	Distribution and Subcellular Localization of High‐Molecular‐Weight Microtubule‐Associated Protein‐2 Expressing Exon 8 in Brain and Spinal Cord Journal of Neurochemistry ·Bridget Shafit‐Zagardo, Nellie Kalcheva, Dennis W. Dickson, Peter Davies, Yvonne Kress	1997	14
19	Immunolocalization and Redistribution of the FAC1 Protein in Alzheimerʼs Disease Journal of Neuropathology & Experimental Neurology ·Barabás Richárd, Peter Davies, Robert Bowser	1996	19
20	Stimulation of choline acetyltransferase activity by retinoic acid and sodium butyrate in a cultured human neuroblastoma Brain Research ·Diana Casper, Peter Davies	1989	31

About Peter Davies

Peter Davies is a scholar working on Physiology, Neurology, Cellular and Molecular Neuroscience, Biological Psychiatry and Neurology, having authored 232 papers that have together received 22.9k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (146 papers), Neuroscience and Neuropharmacology Research (43 papers), Cholinesterase and Neurodegenerative Diseases (26 papers), Parkinson's Disease Mechanisms and Treatments (25 papers), Dementia and Cognitive Impairment Research (25 papers), Prion Diseases and Protein Misfolding (20 papers), Neuroinflammation and Neurodegeneration Mechanisms (19 papers) and Mitochondrial Function and Pathology (13 papers). The work is most often cited by research in Neurology (4.5k citations), Physiology (14.0k citations), Cellular and Molecular Neuroscience (5.9k citations), Neurology (4.2k citations) and Biological Psychiatry (619 citations). Peter Davies has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Dennis W. Dickson, Robert D. Terry, Howard Crystal, Inez Vincent, Benjamin Wolozin, Paula Altman Fuld, Karen Duff, Linda A. Mattiace, Christopher M. Acker and Yvonne Kress. Their work appears in journals such as Neurobiology of Aging, Acta Neuropathologica, Journal of Neuropathology & Experimental Neurology, Journal of Neurochemistry and Journal of Alzheimer s Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact